Christopher Kuebler - Director, Nektar Therapeutics

As of October 1, 2018


Christopher Kuebler Net Worth

  • Net worth is estimated to be at least $19.94M
  • Owns at least 40,500 units of Nektar Therapeutics stock
  • Sold an estimated value of $6.99M in the last 15 years at Nektar Therapeutics

Christopher Kuebler Trading

  • Largest purchase of shares was 30,000 units , worth over $427.8K on January 4, 2018
  • Largest sale of shares was 40,000 units , worth over $3.9M on March 8, 2018
  • In total has made about 29 transactions over 15 years
  • Usually trades in September, with the busiest year in 2015, 2018 and 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Christopher Kuebler Mailing Address

  • Mailing address is 210 Carnegie Center Princeton NJ 08540 NJ

Nektar Therapeutics Insider Trading

  • The most recent transaction was 21,673 units sold on May 17, 2022 by Jonathan Zalevsky worth over $85.61K
  • In the last 19 years, insiders at Nektar Therapeutics sold an estimated value of $294.28M and bought an estimated value of $84.98M
  • The most active traders are Gil Labrucherie, SVP,  Howard Robin, President & CEO,  and Robert Chess, Director
  • Insider trading is most common in September, with the busiest year in 2016 and 2017

NEKTAR THERAPEUTICS Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1